CA2755023C — Antiviral compounds and uses thereof
Assigned to AbbVie Inc · Expires 2016-12-13 · 9y expired
What this patent protects
This invention relates to: (a) compounds, for example, the compound of formula (I): (see formula I) wherein R1, R2, R3 and R4 are as described in the specification, and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and…
USPTO Abstract
This invention relates to: (a) compounds, for example, the compound of formula (I): (see formula I) wherein R1, R2, R3 and R4 are as described in the specification, and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.